Home
>
National Drug Code (NDC)
>
ALDACTAZIDE
ALDACTAZIDE - 0025-1021-31 - (SPIRONOLACTONE and HYDROCHLOROTHIAZIDE)
Drug Information of ALDACTAZIDE
| Product NDC: | 0025-1021 |
| Proprietary Name: | ALDACTAZIDE |
| Non Proprietary Name: | SPIRONOLACTONE and HYDROCHLOROTHIAZIDE |
| Active Ingredient(s): | 50; 50 mg/1; mg/1 & nbsp; SPIRONOLACTONE and HYDROCHLOROTHIAZIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ALDACTAZIDE
| Product NDC: | 0025-1021 |
| Labeler Name: | G.D. Searle LLC Division of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA012616 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19780101 |
Package Information of ALDACTAZIDE
| Package NDC: | 0025-1021-31 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0025-1021-31) |
NDC Information of ALDACTAZIDE
| NDC Code | 0025-1021-31 |
| Proprietary Name | ALDACTAZIDE |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0025-1021-31) |
| Product NDC | 0025-1021 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SPIRONOLACTONE and HYDROCHLOROTHIAZIDE |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19780101 |
| Marketing Category Name | NDA |
| Labeler Name | G.D. Searle LLC Division of Pfizer Inc |
| Substance Name | HYDROCHLOROTHIAZIDE; SPIRONOLACTONE |
| Strength Number | 50; 50 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
